Linden Thomas Advisory Services’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
15,524
-15
-0.1% -$1.55K 0.13% 277
2026
Q1
$1.5M Buy
15,539
+113
+0.7% +$11.6K 0.14% 248
2025
Q4
$1.64M Sell
15,426
-35
-0.2% -$4.06K 0.17% 187
2025
Q3
$1.96M Buy
15,461
+416
+3% +$49.5K 0.2% 152
2025
Q2
$1.84M Sell
15,045
-96
-0.6% -$11K 0.2% 159
2025
Q1
$1.53M Buy
15,141
+15
+0.1% +$1.47K 0.2% 190
2024
Q4
$1.4M Sell
15,126
-167
-1% -$16.4K 0.18% 213
2024
Q3
$1.48M Sell
15,293
-84
-0.5% -$7.55K 0.2% 195
2024
Q2
$1.32M Buy
15,377
+24
+0.2% +$2.01K 0.2% 211
2024
Q1
$1.27M Sell
15,353
-120
-0.8% -$8.79K 0.2% 210
2023
Q4
$1.03M Buy
15,473
+253
+2% +$16.4K 0.19% 227
2023
Q3
$1.02M Buy
15,220
+2,754
+22% +$189K 0.23% 196
2023
Q2
$844K Buy
12,466
+542
+5% +$34K 0.19% 222
2023
Q1
$645K Buy
11,924
+2,253
+23% +$131K 0.16% 243
2022
Q4
$578K Buy
+9,671
New +$526K 0.16% 236

Other funds holding EHC

Linden Thomas Advisory Services's EHC Position: Q2 2026 in Review

Linden Thomas Advisory Services reduced its Encompass Health (EHC) stake by 0.1% in Q2 2026, selling an estimated $1.55K and leaving 15,524 shares worth $1.57M. The position accounts for 0.13% of the portfolio, ranked #277.

Linden Thomas Advisory Services first reported a position in EHC in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.96M in Q3 2025. 81 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Linden Thomas Advisory Services held 15,524 shares of Encompass Health worth $1.57M as of Q2 2026.
  • Linden Thomas Advisory Services sold 15 Encompass Health shares in Q2 2026, an estimated $1.55K.
  • Encompass Health made up 0.13% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #277 holding.
  • Linden Thomas Advisory Services first reported a position in Encompass Health in Q4 2022 and has held it in 15 quarters since.
  • Linden Thomas Advisory Services's Encompass Health position peaked at $1.96M in Q3 2025.
  • 81 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.